Summit Therapeutics Inc. (SMMT) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.93M; Additional Paid in CapitalUSD $3.32B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.67M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.76M; Additional Paid in CapitalUSD $3.02B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.63M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.75M; Additional Paid in CapitalUSD $2.95B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.54M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $7.44M; Additional Paid in CapitalUSD $2.26B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-2.71M.
Summit Therapeutics Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Retained Earnings GBP |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $7.93M | $3.32B | $-2.67M | $-2.70B | $629.98M | 3 month · $3.46M | 3 month · $68.71M | (m) |
| 2026-03-31 | $0.00 | $7.76M | $3.02B | $-2.63M | $-2.48B | $545.93M | (m) | 3 month · $72.79M | (m) |
| 2025-12-31 | $0.00 | $7.75M | $2.95B | $-2.54M | $-2.29B | $658.86M | (m) | 12 month · $732.42M | (m) |
| 2025-09-30 | $0.00 | $7.44M | $2.26B | $-2.71M | $-2.07B | $192.26M | (m) | 3 month · $130.76M | (m) |
| 2025-06-30 | $0.00 | $7.43M | $2.10B | $-2.75M | $-1.84B | $259.44M | (m) | 3 month · $478.78M | (m) |
| 2025-03-31 | $0.00 | $7.42M | $1.62B | $-2.56M | $-1.28B | $344.33M | (m) | 3 month · $11.10M | (m) |
| 2024-12-31 | $0.00 | $7.38M | $1.60B | $-2.29M | $-1.21B | $388.75M | (m) | 12 month · $50.98M | (m) |
| 2024-09-30 | $0.00 | $7.37M | $1.59B | $-2.31M | $-1.15B | $437.92M | 3 month · $1.19M | 3 month · $19.37M 9 month · $39.97M | (m) |
| 2024-06-30 | $0.00 | $7.24M | $1.29B | $-2.50M | $-1.10B | $195.07M | (m) | 3 month · $11.09M 6 month · $20.59M | (m) |
| 2024-03-31 | $0.00 | $7.02M | $1.08B | $-2.45M | $-1.04B | $44.21M | (m) | 3 month · $9.51M | (m) |
| 2023-12-31 | $0.00 | $7.02M | $1.07B | $-2.45M | $-993.26M | $77.69M | 12 month · $619.00K | 12 month · $14.11M | (m) |
| 2023-09-30 | $0.00 | $6.98M | $1.05B | $-2.32M | $-956.69M | $99.38M | 9 month · $619.00K | 3 month · $705.00K 9 month · $5.36M | (m) |
| 2023-06-30 | $0.00 | $6.98M | $1.05B | $-2.44M | $-935.42M | $119.60M | 6 month · $619.00K | 3 month · $1.88M 6 month · $4.65M | (m) |
| 2023-03-31 | $0.00 | $6.98M | $1.05B | $-1.40M | $-920.71M | $133.48M | 3 month · $619.00K | 3 month · $2.77M | (m) |
| 2022-12-31 | $0.00 | $2.11M | $504.77M | $-1.89M | $-378.33M | $126.65M | 12 month · $111.00K | 12 month · $11.95M | (m) |
| 2022-09-30 | $0.00 | $2.01M | $493.55M | $-3.22M | $-359.10M | $133.25M | 3 month · $111.00K 9 month · $111.00K | 3 month · $2.80M 9 month · $9.29M | (m) |
| 2022-06-30 | $0.00 | $981.00K | $391.22M | $-3.17M | $-337.72M | $51.32M | (m) | 3 month · $2.50M 6 month · $6.49M | (m) |
| 2022-03-31 | (m) | $981.00K | $388.33M | $-3.96M | $-320.94M | $64.41M | (m) | 3 month · $4.00M | (m) |
| 2021-12-31 | $0.00 | $980.00K | $384.05M | $-2.20M | $-299.55M | $83.28M | 12 month · $159.00K | 12 month · $12.80M | (m) |
| 2021-09-30 | (m) | $976.00K | $377.21M | $-3.44M | $-272.45M | $102.30M | 3 month · $41.00K 9 month · $159.00K | 3 month · $2.64M 9 month · $7.18M | (m) |
| 2021-06-30 | (m) | $974.00K | $373.88M | $-2.58M | $-252.85M | $119.43M | 3 month · $118.00K 6 month · $118.00K | 3 month · $3.67M 6 month · $4.54M | (m) |
| 2021-03-31 | (m) | $829.00K | $295.13M | $-3.12M | $-228.43M | $64.41M | (m) | 3 month · $868.00K | (m) |
| 2020-12-31 | (m) | $826.00K | $293.37M | $-3.79M | $-210.95M | $79.45M | 12 month · $48.00K | 12 month · $1.77M | (m) |
| 2020-09-30 | (m) | $672.00K | $242.40M | $-7.03M | $-199.17M | $38.55M | (m) | 3 month · $361.00K 9 month · $1.19M | (m) |
| 2020-06-30 | (m) | $672.00K | $242.03M | $-9.29M | $-181.47M | $53.60M | (m) | 3 month · $530.00K 6 month · $827.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $68.41M | (m) | 3 month · $297.00K | -102.49M |
| 2019-12-31 | (m) | $672.00K | $241.20M | $-4.76M | $-158.25M | $78.86M | (m) | 11 month · $845.00K | -97.62M |
| 2019-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -91.84M |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $36.18M | (m) | 3 month · $244.00K 9 month · $848.00K | (m) |
| 2019-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -84.89M |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $43.56M | (m) | 3 month · $264.00K 6 month · $604.00K | (m) |
| 2019-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -79.86M |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $51.24M | (m) | (m) | (m) |
| 2019-01-31 | (m) | $321.00K | $191.21M | $-4.77M | $-130.94M | $57.59M | (m) | 12 month · $6.29M | -76.10M |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $32.17M | (m) | (m) | (m) |
| 2018-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -81.27M |
| 2018-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | -73.14M |
| 2018-01-31 | (m) | $147.00K | $140.57M | $-4.35M | $-140.84M | $-3.59M | (m) | 12 month · $2.09M | -93.92M |
| 2017-01-31 | (m) | (m) | (m) | (m) | (m) | $-4.40M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |